Skip to main content

Peer Review reports

From: Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID-19: a pilot phase II single-arm study, INHIXACOVID19

Original Submission
27 Jul 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
24 Aug 2022 Reviewed Reviewer Report
27 Nov 2022 Reviewed Reviewer Report
10 Dec 2022 Author responded Author comments - Giacomo Fornaro
Resubmission - Version 3
10 Dec 2022 Submitted Manuscript version 3
19 Dec 2022 Author responded Author comments - Giacomo Fornaro
Resubmission - Version 4
19 Dec 2022 Submitted Manuscript version 4
27 Dec 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
30 Apr 2023 Editorially accepted
24 Oct 2023 Article published 10.1186/s12879-023-08297-7

You can find further information about peer review here.

Back to article page